[Prescription of Analgesics in Patients with Rheumatic Diseases in Germany : A claims Data Analysis. German Version]

Overview

Journal Z Rheumatol

Publisher Springer

Specialty Rheumatology

Date 2021 Feb 26

PMID 33635407

Citations 1

Authors

K Albrecht

U Marschall

J Callhoff

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the prescription frequency of analgesics in persons diagnosed with rheumatoid arthritis (RA), axial spondylarthritis (axSpA), psoriatic arthritis (PsA) and systemic lupus erythematosus (SLE) in 2019 using claims data.

Methods: Persons ≥ 18 years insured in 2019 with a diagnosis of RA (M05, M06), axSpA (M45), PsA (M07.0-3) or SLE (M32.1,8,9) were included. Analgesics were identified by the anatomic therapeutic classification (ATC) system. Reported is the percentage of individuals with ≥ 1 analgesics prescription for the respective rheumatic diagnosis in 2019 and for opioids age-standardized in each of the years 2005-2019. In addition, the proportion of long-term opioid use (prescriptions in ≥ 3 consecutive quarter years) in 2006 and 2019 is compared.

Results: Metamizole (29-33%) was the most commonly prescribed analgesic. Nonsteroidal anti-inflammatory drugs (NSAID)/coxibs were prescribed from 35% (SLE) to 50% (axSpA). Of the patients 11-13% were prescribed weak and 6-8% strong opioids. From 2005 to 2019, the proportion of persons with an opioid prescription remained stable, with similar or slightly decreasing proportions of weak opioids and more frequent prescriptions of strong opioids. The proportion of long-term opioid prescriptions increased from 2006 to 2019 from 8.9% to 11.0% (RA), from 6.9% to 9.1% (axSPA), from 7.8% to 9.5% (PsA), and from 7.5% to 8.8% (SLE), corresponding to a 17-24% increase.

Conclusion: The prescription of opioids for persons with inflammatory rheumatic diagnoses is not as high in Germany as in other countries; however, the proportion of long-term prescriptions has considerably increased. The frequent prescription of metamizole is conspicuous.

Citing Articles

Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis: results from phase IV ASTRUM study.

Kiltz U, Baraliakos X, Brandt-Jurgens J, Wagner U, Lieb S, Sieder C Ther Adv Musculoskelet Dis. 2024; 16:1759720X241255486.

PMID: 38846755 PMC: 11155364. DOI: 10.1177/1759720X241255486.

References

Albrecht K, Huscher D, Eidner T, Kleinert S, Spathling-Mestekemper S, Bischoff S . [Medical treatment of rheumatoid arthritis in 2014 : Current data from the German Collaborative Arthritis Centers]. Z Rheumatol. 2016; 76(1):50-57. DOI: 10.1007/s00393-016-0156-5. View

Albrecht K, Luque Ramos A, Callhoff J, Hoffmann F, Minden K, Zink A . [Outpatient care and disease burden of rheumatoid arthritis : Results of a linkage of claims data and a survey of insured persons]. Z Rheumatol. 2017; 77(2):102-112. DOI: 10.1007/s00393-017-0294-4. View

Schneider M, Baseler G, Funken O, Heberger S, Kiltz U, Klose P . [Management of early rheumatoid arthritis : Interdisciplinary guideline]. Z Rheumatol. 2020; 79(Suppl 1):1-38. DOI: 10.1007/s00393-020-00775-6. View

Kiltz U, Braun J . [Current treatment of axial spondylarthritis : Clinical efficacy]. Z Rheumatol. 2019; 79(1):13-22. DOI: 10.1007/s00393-019-00707-z. View

Kim S, Solomon D . Towards defining the safer use of opioids in rheumatology. Nat Rev Rheumatol. 2020; 16(2):71-72. DOI: 10.1038/s41584-019-0360-1. View

Luque Ramos A, Redeker I, Hoffmann F, Callhoff J, Zink A, Albrecht K . Comorbidities in Patients with Rheumatoid Arthritis and Their Association with Patient-reported Outcomes: Results of Claims Data Linked to Questionnaire Survey. J Rheumatol. 2019; 46(6):564-571. DOI: 10.3899/jrheum.180668. View

Marschall U, Lhoest H, Radbruch L, Hauser W . Long-term opioid therapy for chronic non-cancer pain in Germany. Eur J Pain. 2015; 20(5):767-76. DOI: 10.1002/ejp.802. View

Luttosch F, Baerwald C . [Pain management in elderly patients]. Z Rheumatol. 2014; 73(3):233-43. DOI: 10.1007/s00393-013-1244-4. View

Schulze J, Freitag M, Glaeske G, Schmiemann G, Hoffmann F . [Pain medication in nursing home residents with and without cancer. Most frequently with metamizole]. Schmerz. 2015; 29(3):276-84. DOI: 10.1007/s00482-015-0003-7. View

10.

Hoffmann F, Bussche H, Wiese B, Glaeske G, Kaduszkiewicz H . Diagnoses indicating pain and analgesic drug prescription in patients with dementia: a comparison to age- and sex-matched controls. BMC Geriatr. 2014; 14:20. PMC: 3937236. DOI: 10.1186/1471-2318-14-20. View

11.

Lee Y, Kremer J, Guan H, Greenberg J, Solomon D . Chronic Opioid Use in Rheumatoid Arthritis: Prevalence and Predictors. Arthritis Rheumatol. 2018; 71(5):670-677. DOI: 10.1002/art.40789. View

12.

Zamora-Legoff J, Achenbach S, Crowson C, Krause M, Davis 3rd J, Matteson E . Opioid use in patients with rheumatoid arthritis 2005-2014: a population-based comparative study. Clin Rheumatol. 2016; 35(5):1137-44. PMC: 4850553. DOI: 10.1007/s10067-016-3239-4. View

13.

Curtis J, Xie F, Smith C, Saag K, Chen L, Beukelman T . Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United States. Arthritis Rheumatol. 2017; 69(9):1733-1740. DOI: 10.1002/art.40152. View

14.

Machado-Duque M, Ramirez-Valencia D, Murillo-Munoz M, Machado-Alba J . Trends in Opioid Use in a Cohort of Patients with Rheumatoid Arthritis. Pain Res Manag. 2020; 2020:3891436. PMC: 7382740. DOI: 10.1155/2020/3891436. View

15.

Curtis H, Croker R, Walker A, Richards G, Quinlan J, Goldacre B . Opioid prescribing trends and geographical variation in England, 1998-2018: a retrospective database study. Lancet Psychiatry. 2018; 6(2):140-150. DOI: 10.1016/S2215-0366(18)30471-1. View

16.

Chenaf C, Kabore J, Delorme J, Pereira B, Mulliez A, Zenut M . Prescription opioid analgesic use in France: Trends and impact on morbidity-mortality. Eur J Pain. 2018; 23(1):124-134. DOI: 10.1002/ejp.1291. View

17.

Ruchat D, Suter M, Rodondi P, Berna C . [Opioid consumption from 1985 to 2015 : The situation in Switzerland, with an international comparison]. Rev Med Suisse. 2018; 14(612):1262-1266. View

18.

Ashaye T, Hounsome N, Carnes D, Taylor S, Homer K, Eldridge S . Opioid prescribing for chronic musculoskeletal pain in UK primary care: results from a cohort analysis of the COPERS trial. BMJ Open. 2018; 8(6):e019491. PMC: 6009475. DOI: 10.1136/bmjopen-2017-019491. View

19.

Dau J, Lee M, Ward M, Gensler L, Brown M, Learch T . Opioid Analgesic Use in Patients with Ankylosing Spondylitis: An Analysis of the Prospective Study of Outcomes in an Ankylosing Spondylitis Cohort. J Rheumatol. 2017; 45(2):188-194. PMC: 5805598. DOI: 10.3899/jrheum.170630. View

20.

Rosner B, Neicun J, Yang J, Roman-Urrestarazu A . Opioid prescription patterns in Germany and the global opioid epidemic: Systematic review of available evidence. PLoS One. 2019; 14(8):e0221153. PMC: 6713321. DOI: 10.1371/journal.pone.0221153. View